2,488
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis

, , , , , , & ORCID Icon show all
Article: 2300848 | Received 12 Aug 2023, Accepted 27 Dec 2023, Published online: 04 Jan 2024

ABSTRACT

This review quantified the association of vaccine literacy (VL) and vaccination intention and status. PubMed, Scopus, and Web of Science were searched. Any study, published until December 2022, that investigated the associations of interest were eligible. For each outcome, articles were grouped according to the vaccine administrated and results were narratively synthesized. Inverse-variance random-effect models were used to compare standardized mean values in VL domain(s) between the two groups: individuals willing vs. unwilling to get vaccinated, and individuals vaccinated vs. unvaccinated. This review of 18 studies shows that VL strongly predicts the vaccination intention while its association with vaccination status is attenuated and barely significant, suggesting that other factors influence the actual vaccination uptake. However, given the scarce evidence available, the heterogeneity in the methods applied and some limitations of the studies included, further research should be conducted to confirm the role of VL in the vaccination decision-making process.

View responses to this article:
The still unexplored mediating role of vaccine literacy
The role of vaccine literacy and health literacy in the health prevention decision-making process

Introduction

Immunization is considered a key component of primary health care and an indisputable human right.Citation1 Vaccines help prevent and control infectious-disease outbreaks, as well as antimicrobial resistance,Citation2–4 and they also have a critical role in cancer prevention.Citation5–7 New vaccines are currently available or in the pipeline for long-standing deadly diseases, including malaria and tuberculosis,Citation8 while research on therapeutic vaccination is opening up new horizons in medicine.Citation9 Despite the undeniable importance of vaccines, the COVID-19 pandemic triggered widespread disinformation on vaccination, undermining the understanding and acceptance of science and health policies,Citation10 including vaccine adherence.Citation11 Alongside, structural barriers, such as the geographical distance to healthcare centers, limited service hours but also reduced availability of the health workforce,Citation12,Citation13 caused an unprecedented and sustained decline in immunization coverage, leaving 25 million children unvaccinated or under-vaccinated for routine immunizations in 2021.Citation14

In this context, several factors have been investigated by researchers to assess their influence on vaccination behavior, including vaccine literacy (VL).Citation15–17 Vaccine literacy, a form of health literacy (HL), is a relatively new concept.Citation18 Although a single and unambiguous definition is still lacking, the Health Literacy Survey Consortium defines it as “individuals’ knowledge, motivation, and skills to find, understand, and evaluate immunization-related information in order to make adequate immunization decisions”.Citation19 Similarly to HL, it is affected by several factors including socio-economic status and level of education. Accordingly, VL has been proposed to affect vaccination acceptance and therefore could be a means of tackling vaccine hesitancy.Citation20

Several researchers have studied VL in relation to vaccination behavior,Citation21 but despite the growing number of studies on this topic,Citation21,Citation22 a few limitations have contributed to the poor generalizability of the results, including small sample sizes, narrowly defined target populations, and differences in the vaccines investigated and the scales or sub-scales used for VL measurement.Citation18,Citation21,Citation23 Furthermore, the evidence presented has largely been inconclusive, with no clear relationship between VL and vaccination behavior emerging to date.Citation21,Citation22 Therefore, we conducted a systematic review and meta-analysis to synthesize the evidence on this topic and provide a quantitative estimate of the association between VL and vaccination behavior, considering both intention and vaccination status. The results may contribute to a better understanding of VL as a potential predictor of vaccination adherence and may point toward more targeted strategies for implementing vaccination adherence.

Materials and methods

This study was performed according to the Cochrane Handbook for Systematic Reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.Citation24,Citation25 The review protocol was registered at PROSPERO (identifier CRD42022381807). Since primary data collection was not performed, informed consent was not required, and the protocol was not submitted for institutional review board approval.

Search strategy and study selection

We searched the bibliographic databases PubMed, Web of Science and Scopus using the following search terms: (“vaccin*” AND “literacy”) OR (“vaccine literacy”). The string adaptation to fit the search criteria of each database is shown in Supplementary Table S1. The search was conducted among records published from database inception to 28 December 2022. No language or date restrictions were applied. After the removal of duplicate records, three reviewers independently screened the title and abstract of all records retrieved. Studies that did not meet the inclusion criteria were excluded and three researchers examined the full texts of potentially relevant articles. Disagreements were resolved through discussion and reasons for exclusion were recorded.

Inclusion and exclusion criteria

We included studies that i) reported in English or Italian, based our coauthor language abilities; ii) had an observational design (i.e., cohort, case-control, cross-sectional); iii) investigated at least one domain of general or vaccine-specific VL (e.g., COVID-19 VL); and iv) provided raw data, unadjusted or adjusted estimates of the association between VL and vaccination intention and/or status in any population(s). Any statistical analysis was considered eligible. Articles that analyzed vaccination acceptance (i.e., a combination of vaccination intention and status) or in which data or estimates of the associations of interest were not described or retrievable were excluded.

Data collection and quality assessment

For each record included, three reviewers independently extracted the following information using a standardized data abstraction form: first author, year of publication, country, study design, main characteristics (age, ethnicity, recruitment process, and number of participants) of target population, type of vaccine (e.g., against SARS-CoV-2, HPV, etc.), tools used to assess VL and the domain(s) investigated, outcome definition and measurement, statistical analysis, main findings, and adjustment factors (if applicable). The sample size was categorized in low (<100 participants), medium (101–1000 participants), large (1001–1000 participants) and very large (>10000 participants). Quality assessment of the articles included was carried out by three independent authors, using an adapted version for cross-sectional studies of the Newcastle-Ottawa scale.Citation26 Articles were considered of high quality when the total score was ≥7, of fair quality if the score was ≥5 and <7, and of poor quality if the score was lower than 5.Citation27 Discrepancies were resolved through discussion and achievement of consensus.

Data synthesis and statistical analysis

Two main outcomes were investigated: intention to be vaccinated and vaccination status. Then, for each outcome, articles were grouped according to the type of vaccine and a narrative synthesis of the main findings was performed. In addition, inverse-variance random-effect meta-analyses were conducted to pool standardized mean differences (SMD) in VL scores between two groups: for the vaccination intention outcome, individuals that were willing to be or were sure about being vaccinated vs. individuals that were unwilling or unsure; for the vaccination status outcome, individuals that were vaccinated vs. those that were unvaccinated. As for the VL domains, since they investigate different capabilities of individuals, we considered separately overall VL, functional VL, interactive VL, critical VL and interactive/critical VL. Indeed, according to Biasio et al., functional VL regards language capabilities, encompassing the semantic system, while interactive/critical domains focus on cognitive efforts such as problem solving and decision making.Citation28 Studies that did not report the mean levels of these VL domains in each group, or in which the mean values were not retrievable, were excluded from the meta-analysis. The Cochrane χ2 test and the I2 metric were used to test for heterogeneity.Citation29 Heterogeneity was considered statistically significant at p-value <.05, and substantial heterogeneity was defined as ICitation2 > 50%. For both outcomes, whenever possible, we stratified studies by a few variables that could influence heterogeneity: type of vaccine considered (i.e., SARS-CoV-2 booster dose, SARS-CoV-2 primary cycle, or influenza), by VL tool used (i.e., Adult Vaccination Health Literacy in Italian [HLVa-IT], COVID-19 Vaccine Literacy Scale [COVID-19 VLS], or others), and by target population (i.e., general population, with no particular features, or specific populations). Since one studyCitation30 reported data on the willingness to receive two types of vaccine separately (i.e., SARS-CoV-2 and influenza) but in the same population, and we did not want to lose any information, we first pooled the data on SARS-CoV-2, while the data on influenza vaccination was used instead in a sensitivity analysis. In addition, since the number of studies retrieved was always lower than 10 within each analysis, we followed the Cochrane guidelinesCitation25 such that the small study effect, potentially caused by publication bias, was not assessed. For a similar reason, given the limited availability of studies within each outcome, meta-regression analyses were not performed. A p-value < .05 was considered statistically significant. All analyses and graphs were performed using Review Manager (RevMan, The Cochrane Collaboration, 2020), version 5.4, and GraphPad Prism (GraphPad Software, San Diego, California USA), version 9.0.

Results

Overall, 3326 records were identified by database searching (). After duplicate removal and screening by title and abstract, 61 articles were assessed for eligibility, of which 43 were excluded with reasons at the full-text analysis stage, providing a total of 18 articles for inclusion in the systematic review: of these, nine studies (50.0%) investigated intention to vaccinate,Citation31–39 four studies (22.2%) explored vaccination statusCitation28,Citation40–42 and five studies (27.8%) considered both outcomes separately.Citation30,Citation43–46 For the meta-analysis, 10 articles (55.6%) provided estimates that were ultimately pooled.

Figure 1. PRISMA flow diagram of the review process. VL: vaccine literacy.

Figure 1. PRISMA flow diagram of the review process. VL: vaccine literacy.

Characteristics of the studies included in the systematic review

Studies investigating vaccination intention only

All nine studies that only investigated vaccination intention were published in 2021Citation31–35 or 2022Citation36–39 and had a cross-sectional designCitation31–39 (). Two were conducted in the United States,Citation35,Citation37 two in Saudi Arabia,Citation31,Citation38 one in Israel,Citation32 one in Croatia,Citation33 one in Bangladesh,Citation34 one in IndiaCitation36 and one in Japan.Citation39 The general population was investigated in the majority of studies,Citation33–38 while in two cases the sample was enrolled from COVID-19 booster-hesitant individuals.Citation36,Citation37 One study recruited parents of adolescent childrenCitation32 whereas in two articles university students were targeted,Citation31,Citation39 with one restricting the investigation to nursing students.Citation31 In all but two studies the recruitment process was performed online using social networksCitation32–34,Citation38 or commercial panels.Citation35–37 A large sample size (i.e., more than 1000) was enrolled in four studies.Citation31,Citation33,Citation35,Citation38 All but one study investigated the SARS-CoV-2 vaccineCitation31–38 (primary or booster vaccination), with the exception focusing on human papillomavirus (HPV) vaccine.Citation39 Quality was judged to be high in six studiesCitation31,Citation34–38 and fair in the remaining three articles,Citation32,Citation33,Citation39 in which the main deficits were issues with the sample used (insufficiently representative; no justification for sample size) and a lack of data on the comparability between survey participants and non-participants (Supplementary Table S2).

Table 1. Characteristics of the studies included in the systematic review.

Studies investigating vaccination status only

Of the four studies that only explored vaccination status, one was published in 2015,Citation40 one in 2020Citation28 and two in 2022Citation41,Citation42 (). One study was conducted in Turkey,Citation42 one in the United States,Citation40 one in ItalyCitation28 and one in South Africa.Citation41 All studies had a cross-sectional design.Citation28,Citation40–42 The target population was the general population in two articles, enrolled either onlineCitation41 or in healthcare settings,Citation28 and comprised university students in the two remaining cases,Citation40,Citation42 with one study focusing on nursing science.Citation42 The ethnicity of the participants was specified in only one article.Citation40

The sample was very large (i.e., more than 10,000 participants) in only one studyCitation41; the other studies were large (i.e., more than 1000 people)Citation40 or medium (i.e., more than 100 people)Citation28,Citation42 in scale. Two articles looked at SARS-CoV-2 vaccine,Citation41,Citation42 one investigated HPV vaccinationCitation40 and one considered combined vaccination against influenza, Pneumococcus and tetanus (IPT).Citation28 All studies were judged of high or fair quality. A lack of data comparing the characteristics between survey participants and non-participants was the main deficit (Supplementary Table S2).

Studies investigating both vaccination intention and status

The five studies that investigated both vaccination intention and status were published in 2020Citation30 or 2022Citation43–46 (). All studies had a cross-sectional design.Citation30,Citation43–46 In each case, a single study was conducted in Italy,Citation30 Barbados,Citation43 Thailand,Citation44 SpainCitation45 and China.Citation46 The population enrolled varied: in two cases the sample included individuals from a medical foundationCitation30 or patients with autoimmune diseasesCitation45; one recruited healthcare professionals,Citation43 while two targeted the general population either aged ≥18 yearsCitation46 or aged ≥60 years.Citation44 The recruitment process always took place online, using social networksCitation44–46 or e-mail addresses.Citation30,Citation43 The sample size was deemed to be medium in all studies considered (i.e., more than 100).Citation30,Citation43–46 Vaccination against SARS-CoV-2 was explored in all articles,Citation30,Citation43–46 three of which also investigated flu vaccination.Citation30,Citation43,Citation45 Quality was fair in all but one study,Citation44 which had no justification of the sample size and lacked comparability between responders and non-responders (Supplementary Table S2).

Main findings

Association between VL and vaccination intention

Systematic review

Out of 13 studies that investigated the participants’ intention to be vaccinated against SARS-CoV-2, seven used the original or an adapted version of the HLVa-IT tool,Citation30,Citation31,Citation35–37,Citation45,Citation46 five adopted the COVID-19 VLS questionnaire,Citation32–34,Citation38,Citation44 whereas an ad hoc questionnaire was developed in the remaining caseCitation43 (). Vaccine literacy was reported as a scale in all studies includedCitation30–38,Citation43–46: two studies provided data both on some VL domains and on the overall VL score,Citation32,Citation46 seven articlesCitation30,Citation31,Citation33,Citation35,Citation38,Citation43,Citation45 analyzed VL domains only (i.e., functional, interactive and critical), while in four casesCitation34–36,Citation44 only an overall VL score was provided. Vaccination intention was explored using oneCitation30,Citation31,Citation33-38,Citation43–46 or two self-reported questions.Citation32 Participant answers were dichotomized in the majority of studies,Citation30,Citation32,Citation33,Citation35–38,Citation43,Citation45,Citation46 but were divided into three categories in two cases,Citation31,Citation44 whereas only one study expressed the outcome as a mean score of agreement to vaccination.Citation34 Four out of thirteen articles performed regression models as the main method of analysis,Citation31,Citation34,Citation36,Citation37 while the others used univariable analyses, comparing mean or median values between groups.Citation30,Citation32,Citation33,Citation35,Citation38,Citation43–46. Results were heterogeneous: for the univariable analyses, all VL domains seemed to influence the intention to have primary or booster vaccination in six studies,Citation33,Citation35–37,Citation43,Citation44 but the association remained significant in only oneCitation37 out of the two studies, which also performed a multivariable analysis after restricting the sample to hesitant participants.Citation36,Citation37 Conversely, none of the VL levels seemed to influence vaccination intention in the other four univariable analyses,Citation32,Citation34,Citation45,Citation46 even in the two studies that adjusted the analysis for socio-demographic characteristics or COVID-19 experience, beliefs and attitudes.Citation31,Citation34 Lastly, inconclusive findings were reported by Biasio et al. and Gutierrez et al., in which higher interactive/critical VL levels were found to be positively associated with vaccination intention in unadjusted analyses, whereas the functional domain was not.Citation30,Citation38

Table 2. Association between vaccine literacy (VL) and vaccination intention.

Influenza vaccination was evaluated in one study.Citation30 VL was measured with an adapted version of the HLVa-IT tool and its levels were used as a mean score, after considering separately functional and interactive/critical domains. Vaccination intention was investigated with one question on the willingness to obtain flu vaccination in the current year, and the answers were dichotomized. In a univariable analysis, a significant association was found between higher functional and interactive/critical VL levels and the intention to be vaccinated.

One study explored HPV vaccination intention in male and female university students using an ad hoc questionnaire that provided a mean score of overall VL levels.Citation39 The outcome was calculated as time to receive the HPV vaccination and answers were collapsed into two categories, i.e., immediately to within three years vs. no intention to get vaccinated. Higher overall VL levels seemed to positively predict the intention to be vaccinated only in the male sample, according to a univariable analysis, even after adjusting for socio-demographic factors.

Meta-analysis

In our meta-analysis, we found a statistically significant association between the intention to be vaccinated and overall VL score (N = 3, SMD = 0.51, 95% CI: 0.20 to 0.82, I2 = 89.0%), functional VL (N = 7, SMD = 0.34, 95% CI: 0.10–0.58, I2 = 94.0%), interactive VL (N = 3, SMD = 0.42, 95% CI: 0.17 to 0.68, I2 = 90.0%), critical VL (N = 3, SMD = 0.50, 95% CI: 0.38 to 0.61, I2 = 54.0%) and interactive/critical VL (N = 5, SMD = 0.42; 95% CI: 0.21 to 0.62, I2 = 84.0%) (). Stratifying by vaccination, the intention to have the SARS-CoV-2 booster dose seemed to be associated with higher VL levels in all domains explored (functional VL: N = 3, SMD = 0.63, 95% CI: 0.45 to 0.81, I2 = 81.0%; interactive VL: N = 3, SMD = 0.42, 95% CI: 0.17 to 0.68, I2 = 90.0%; critical VL: N = 3, SMD = 0.50, 95% CI: 0.38 to 0.61, I2 = 54.0%), whereas for the primary vaccination cycle only higher interactive/critical VL appeared to positively influence vaccination intention (N = 5, SMD = 0.42, 95% CI: 0.21 to 0.62, I2 = 84.0%) (, Supplementary Figure S1). Stratification by tool provided similar findings, with higher levels of VL in the functional, interactive and critical domains, as measured by the HLVa-IT tool, being associated with willingness to be vaccinated (functional VL: N = 4, SMD = 0.52, 95% CI: 0.28 to 0.75, I2 = 89.0%; interactive VL: N = 3, SMD = 0.42, 95% CI: 0.17 to 0.68, I2 = 90.0%; and critical VL: N = 3, SMD = 0.50, 95% CI: 0.38 to 0.61, I2 = 54.0%), whereas higher levels of interactive/critical VL, as detected by the COVID-19 VLS tool, seemed not to influence willingness to be vaccinated (N = 2, SMD = 0.35, 95% CI: −0.14 to 0.84, I2 = 95.0%) (, Supplementary Figure S2). Stratifying by population found a statistically significant association between vaccination intention and a high VL score in all domains in the general population only (functional VL: N = 5, SMD = 0.42, 95% CI: 0.12 to 0.71, I2 = 96.0%; interactive VL: N = 3, SMD = 0.42, 95% CI: 0.17 to 0.68, I2 = 90.0%; critical VL: N = 3, SMD = 0.50, 95% CI: 0.38 to 0.61, I2 = 54.0%; and interactive/critical VL: N = 2, SMD = 0.59, 95% CI: 0.49 to 0.70, I2 = 0.0%) (, Supplementary Figure S3). In a sensitivity analysis, when we used data from Biasio et al.Citation30 on influenza vaccination instead of SARS-CoV-2, the results did not change meaningfully for either the functional or the interactive/critical VL domains (functional VL: N = 7, SMD = 0.36; 95% CI: 0.14 to 0.58, I2 = 94.0%; interactive/critical VL: N = 5, SMD = 0.41; 95% CI: 0.22 to 0.59, ICitation2 = 83.0%) (, Supplementary Figure S4–6).

Figure 2. Stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of individuals willing to be or sure about being vaccinated vs. unwilling or unsure individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale. HLVa-IT: Adult vaccination health literacy in Italian.

Figure 2. Stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of individuals willing to be or sure about being vaccinated vs. unwilling or unsure individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale. HLVa-IT: Adult vaccination health literacy in Italian.

Figure 3. Sensitivity analysis of stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of individuals willing to be or sure about being vaccinated vs. unwilling or unsure individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale. HLVa-IT: Adult vaccination health literacy in Italian.

Figure 3. Sensitivity analysis of stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of individuals willing to be or sure about being vaccinated vs. unwilling or unsure individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale. HLVa-IT: Adult vaccination health literacy in Italian.

Association between VL and vaccination status

Systematic review

One study investigated HPV vaccine uptake in female university students, distinguishing two different ethnicities and using an ad hoc questionnaire to measure VL levelsCitation40 (). A multivariable analysis was performed to evaluate the association between higher overall VL and the self-reported completion of the vaccination protocol (three HPV doses). After adjustment for both sociodemographic and HPV-related factors, a significant association in both sub-groups was found.

Table 3. Association between vaccine literacy (VL) and vaccination status.

Biasio et al. studied IPT vaccination using the HLVa-IT tool and found in a univariable analysis a significant association between the receipt of at least one vaccine (i.e., tetanus booster every 10 years, or pneumococcal and influenza vaccination for people aged ≥65 years) and higher VL scores in the functional domain only.Citation28

Three studies considered influenza vaccination only.Citation30,Citation43,Citation45 They used different VL tools and analyzed the association between functional and/or interactive/critical VL with self-reported last-season vaccination status in a univariable analysis. The results were contrasting: higher VL levels (both functional and interactive/critical) were found to be significantly associated with previous flu vaccination uptake in the study by Biasio et al.,Citation30 but not in the study by Correa-Rodriguez et al.Citation45 Similarly, higher interactive/critical VL levels seemed not to predict the uptake of flu vaccination in the analysis conducted by Krishnamurty et al..Citation43

Current vaccination status for SARS-CoV-2 was considered in four studies,Citation41,Citation42,Citation44,Citation46 using the COVID-19 VLS tool in two casesCitation42,Citation44 or an adapted version of the HLVa-IT tool in the other two casesCitation41,Citation46 to evaluate VL levels. One study investigated only overall VL,Citation44 whereas the others reported data on at least two domains.Citation41,Citation42,Citation46 Vaccination status was always assessed by a self-reported question and the answers were dichotomized in all studiesCitation41,Citation42,Citation44 but one, in which the outcome was divided into four groups in relation to the number of doses received.Citation46 The results were heterogenous: significantly higher functional and interactive/critical VL levels were found among vaccinated individuals in the only study in which adjusted estimates were provided.Citation41 Conversely, neither overall VL nor any VL domain seemed to be predictors of COVID-19 vaccine uptake in the univariable analyses conducted by Kittipimpanon et al. and Li et al., respectively,Citation44,Citation46 while inconclusive findings were recorded in the study of Yilmaz et al., in which higher functional VL seemed to be positively associated with COVID-19 vaccination adherence in a univariable analysis, but not interactive/critical VL.Citation42

Meta-analysis

In our meta-analysis, we found a nonstatistically significant association between being vaccinated and overall VL score (N = 2, SMD = 0.17, 95% CI: −0.01 to 0.35, I2 = 0.0%), or in relation to functional VL score (N = 3, SMD = 0.23, 95% CI: −0.11 to 0.57, I2 = 82.0%) but a significant association for interactive/critical VL score (N = 4, SMD = 0.22, 95% CI: 0.04 to 0.39, I2 = 52.0%) (). After stratifying by vaccine, being vaccinated for SARS-CoV-2 was significantly associated with higher mean functional VL scores but not with interactive/critical VL values (N = 1, SMD = 0.60, 95% CI: 0.07 to 1.14; and N = 1, SMD = 0.25, 95% CI: −0.28 to 0.79, respectively), whereas being vaccinated for influenza was not associated with VL in any of the domains investigated (functional VL: N = 2, SMD = 0.13, 95% CI: −0.26 to 0.52, I2 = 89.0%; interactive/critical VL: N = 3, SMD = 0.21, 95% CI: 0.00 to 0.41, I2 = 68.0%) (, Supplementary Figure 7). Stratification by VL tool provided similar results, with the COVID-19 VLS instrument showing significantly higher mean VL values among vaccinated people in the functional domain only (N = 1, SMD = 0.60; 95% CI: 0.07 to 1.14) (, Supplementary Figure 8). Lastly, stratification by target population indicated a statistically significant association between vaccination status and high functional and interactive/critical VL scores in the general population only (N = 1, SMD = 0.32, 95% CI: 0.18 to 0.45; and N = 1, SMD = 0.36, 95% CI: 0.22 to 0.49, respectively) (, Supplementary Figure S9).

Figure 4. Stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of vaccinated vs. unvaccinated individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale.

Figure 4. Stratified standardized mean difference (SMD) of vaccine literacy (VL) scores of vaccinated vs. unvaccinated individuals. CI: confidence interval. COVID-19 VLS: COVID-19 vaccine literacy scale.

Discussion

Despite the apparent lack of conclusive evidence from the narrative synthesis of the results, the meta-analysis did find that VL is a strong predictor of vaccination intention, while its association with vaccination status is attenuated and barely significant. This finding is not unexpected,Citation21,Citation22 given that vaccination intention may not always align with actual behavior.Citation27 Other factors, such as the availability and proximity of vaccination centers, the availability of an easy way to book vaccination appointments, or the various funding/reimbursement schemes can play a role in vaccination uptake.Citation47,Citation48 In addition, despite all stratifications made, results were similar, probably because the stratification variables are correlated to some extent. As for the different domains investigated, it is well known that they reflect distinct abilities; thus, functional questions deal with language skills while the interactive and critical tasks involve problem-solving and decision-making processes.Citation28 Hence, although with different magnitudes, the strongest associations found between critical and interactive/critical VL and vaccination intention and status, may be attributable to the different capabilities targeted by the various domains, especially in relation to vaccination status where individuals must act to become vaccinated. However, it is also worth mentioning that all studies included in the critical domain analyzed the intention to have the SARS-CoV-2 booster dose, which showed a robust connection with VL, probably because individuals with a high level of VL are particularly aware of the importance of maintaining high levels of immunity over time. Conversely, the associations between the individual VL domains and vaccination status were all attenuated, with only the analysis with the greatest number of studies included reaching statistical significance. For this reason, more studies are needed to help establish the influence of VL on the actual uptake of vaccination, possibly using observational designs other than cross-sectional studies.Citation27 In addition, these studies should also better specify the definition of the outcome, which in some cases was unclear,Citation41,Citation42,Citation44 and confirm the vaccination status of their participants, allowing a more accurate measurement of the outcome.

Regarding the assessment of vaccination intention, a recent meta-analysis found that the number of possible answers to the question on COVID-19 vaccination intention influenced the pooled estimates of vaccine acceptance.Citation49 In our review, most studies analyzed vaccination intention using binary answers (i.e., yes or no), some of which isolated those who were sure about the vaccine from the individuals that were unsure or completely unwilling.Citation32,Citation36,Citation43 In the other cases, it was not specified whether there were only two possible answers or, alternatively, how the individuals that were uncertain about getting vaccinated were considered in the analyses.Citation30,Citation33,Citation35,Citation38,Citation45,Citation46 While the first approach could overestimate levels of vaccination intention,Citation49 and potentially also affect the estimate of the association with VL, the effect of the second option depends on how the categories were collapsed. For this reason, being more explicit about how the outcome was assessed, as well as using validated tools that differentiate levels of vaccination intention, could improve its estimation and therefore also its association with VL.Citation31,Citation34,Citation44 As for the exposure assessment, even though a common definition and scope of VL are still under discussion,Citation22 we found that very few instruments were used to assess VL levels, with the most widely applied being the HLVa-IT tool. Given that VL and HL are strictly related,Citation20,Citation27 but a clear correlation between HL and vaccine adherence has not always been found,Citation27 it is not surprising that the HLVa-IT tool was developed using scales previously used to assess HL levels.Citation28,Citation50 However, even though the HLVa-IT instrument seemed to predict the outcomes of interest better than the other tools, consideration should be given to developing a commonly shared instrument that takes into account the differences among populations, including cultural beliefsCitation51 and the socio-demographic characteristics of the sample.Citation40,Citation52 In this regard, recent efforts were made to provide a validated and internationally applicable tool for VL measurement with the development of HLS19-VAC.Citation19 Despite its scarce use in the literature to date, this instrument could provide a comprehensive measurement of the VL concept at European level and allow a better comparison of evidence.

Notably, we found a stronger association between VL and intention to be vaccinated among general population, even though most of the studies recruited individuals using the internet, a factor that may challenge the representativeness of these samples.Citation53 On the other hand, the few studies that focused on healthcare workersCitation43 or nursing studentsCitation31,Citation42 found mixed evidence of an association between VL and both outcomes, suggesting that this category should be further investigated, especially considering the implications that this finding may have for both the subjects themselves and the patients they care for.Citation54 Further consideration could be given to the limited type of vaccines under assessment: almost all studies that quantified the intention to vaccinate focused on COVID-19 vaccination, probably because of the availability of new vaccines and their unknown impact on population attitudes and perceptions.Citation27 In this regard, the strong relationship between VL and the intention to have the COVID-19 booster has already been mentioned, even though this review did not arrive at a conclusive judgment on the role of VL in hesitant individuals.Citation37 By contrast, slightly more variety in the type of vaccine studied was found for vaccination status, but the findings were largely inconsistent for most vaccinations. Indeed, while some positive results were reported for both the intention to have the HPV vaccinationCitation39 and the completion of the vaccination protocol,Citation40 we found that being vaccinated against influenza, SARS-CoV-2 or IPT did not seem to be strongly related to VL, in contrast to other individual factors, such as education level and income, that were found to be more involved in these vaccination decision-making processes. As previously discussed, a positive attitude toward vaccination may not always be followed by vaccination uptake,Citation27 particularly for routine immunizations, such as influenza or IPT. In such cases, a perception of low risk of infection, together with some aspects of vaccine convenience, including the quality of vaccination service and the time and place for getting the vaccination, could be neglected.Citation55 This may also explain why VL did not seem to be associated with flu vaccination status either in healthcare workers or in individuals with a chronic disease, two population subgroups that are usually health literate and well aware of the importance of vaccinations.Citation55,Citation56

This study has some strengths and limitations. First, we included articles that measured VL using both validated and non-validated tools, meaning that the reliability of some VL estimates may be sub-optimal. Second, since our focus was VL, we did not include studies that used ambiguous terms, such as ‘literacy on vaccinations’, with no clear definition. Third, since the high heterogeneity in the methods used and the few multivariable analyses carried out, we were only able to pool unadjusted estimates. Furthermore, since data was limited, some uncertainties remain, also considering that it was not possible to assess publication bias or conduct meta-regression analyses. The other limitations are mostly related to the primary studies included in this review. Given that our results are based on self-reported outcomes, social desirability bias could have affected the accuracy of our conclusions. Similarly, narrowly defined populations and questionable enrollment procedures may limit the generalizability of our findings. In addition, since all studies adopted a cross-sectional design, we could not draw any causal conclusions. For these reasons, further research should be conducted at both regional and national level, possibly using standardized methodologies in the design and analysis phases. However, to the best of our knowledge, this is the first study that provides a quantitative synthesis of the association between VL and vaccination behavior, considering separately the different VL domains and two aspects of the decision-making process (i.e., vaccination intention and status).

Conclusions

This review shows that VL strongly predicts vaccination intention, while its association with vaccination status is less marked and only marginally significant, meaning that additional factors may influence vaccination uptake. However, due to the paucity of available evidence, the heterogeneity of the methods employed, and the limitations of the studies included, it is crucial that further research be conducted to better clarify the role of VL in the vaccination decision-making process.

Author contributions

CI and VB were responsible for conceptualization and project management, search design and execution. VB supervised the study. CI, JI, AS, ER and MB were responsible for screening, data extraction, quality assessment and interpretation. CI prepared the first draft. VB, CM and PV were responsible for revisions and approval to submit manuscript.

Supplemental material

Supplementary material_clean.docx

Download MS Word (5.4 MB)

Disclosure statement

No potential conflict of interest was reported by the author(s).

Supplementary material

Supplemental data for this article can be accessed on the publisher’s website at https://doi.org/10.1080/21645515.2023.2300848.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

References

  • World Health Organization. Immunization Agenda 2030 - A global strategy to leave no one behind. WHO [Internet] 2021. https://www.who.int/immunization/ia2030_Draft_One_English.pdf?ua=1.
  • Esposito S, Principi N. Influenza vaccination and prevention of antimicrobial resistance. Expert Rev Vaccines [Internet]. 2018;17(10):881–16. doi:10.1080/14760584.2018.1525298.
  • Maugeri A, Barchitta M, Agodi A. Vaccination coverage in Italian children and antimicrobial resistance: an ecological analysis. Antimicrob Resist Infect Control [Internet]. 2022;11(1):1–13. doi: 10.1186/s13756-022-01173-0.
  • Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S Impact of vaccines on antimicrobial resistance. Int J Infect Dis [Internet]. 2020;90:188–96. doi:10.1016/j.ijid.2019.10.005.
  • Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575–90. doi:10.1016/S0140-6736(20)30068-4.
  • Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591–603. doi:10.1016/S0140-6736(20)30157-4.
  • World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020 – 2030 [Internet]. 2020. https://www.who.int/publications/i/item/9789240014107.
  • World Health Organization (WHO). Tracking the New Vaccine Pipeline [Internet]. [accessed 2022 Dec 4]. https://www.who.int/teams/regulation-prequalification/eul/eul-vaccines/tracking-the-new-vaccine-pipeline.
  • Blass E, Ott PA. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines. Nat Rev Clin Oncol [Internet]. 2021;18(4):215–29. doi:10.1038/s41571-020-00460-2.
  • de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet [Internet]. 2020;396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • . OECD. Enhancing public trust in COVID-19 vaccination: the role of governments. OECD Science and Technology in Indian Policy Paper; 2021. 1–27.
  • Shet A, Carr K, Danovaro-Holliday MC, Sodha SV, Prosperi C, Wunderlich J, Wonodi C, Reynolds HW, Mirza I, Gacic-Dobo M, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health [Internet]. 2022;10(2):e186–94. doi:10.1016/S2214-109X(21)00512-X.
  • Jacoby KB, Hall-Clifford R, Whitney CG, Collins MH. Vaccination and vacci-notions: understanding the barriers and facilitators of COVID-19 vaccine uptake during the 2020-21 COVID-19 pandemic. Public Health Pract [Internet]. 2022;3:100276. doi:10.1016/j.puhip.2022.100276.
  • World Health Organization (WHO). Weekly epidemiological record [Internet]. 2023. http://www.who.int/wer.
  • Ratzan SC. Vaccine literacy: a new shot for advancing health. J Health Commun. 2011;16(3):227–9. doi:10.1080/10810730.2011.561726.
  • Badua AR, Caraquel KJ, Cruz M, Narvaez RA. Vaccine literacy: A concept analysis. Int J Ment Health Nurs. 2022;31(4):857–67. doi:10.1111/inm.12988.
  • Biasio LR. Vaccine hesitancy and health literacy. Hum Vaccines Immunother [Internet]. 2017;13(3):701–2. doi: 10.1080/21645515.2016.1243633.
  • Biasio LR. Vaccine literacy is undervalued. Hum Vaccines Immunother [Internet]. 2019;15(11):2552–3. doi: 10.1080/21645515.2019.1609850.
  • The HLS19 consortium of the WHO action network M-POHL. International report on the methodology, results, and recommendations of the European health literacy population survey 2019–2021 (HLS19) of M-POHL. Vienna: 2021.
  • Michel JP, Goldberg J. Education healthy ageing and vaccine literacy. J Nutr Health Aging. 2021;25(5):698–701. doi:10.1007/s12603-021-1627-1.
  • Biasio LR, Zanobini P, Lorini C, Monaci P, Fanfani A, Gallinoro V, Cerini G, Albora G, Del Riccio M, Pecorelli S, et al. COVID-19 vaccine literacy: a scoping review. Hum Vaccines Immunother [Internet]. 2023;19(1):1–27. doi:10.1080/21645515.2023.2176083.
  • Zhang E, Dai Z, Wang S, Wang X, Zhang X, Fang Q. Vaccine literacy and vaccination: a systematic review. Int J Public Health. 2023;68:1–7. doi:10.3389/ijph.2023.1605606.
  • Biasio LR, Zanobini P, Lorini C, Bonaccorsi G. Relevance of vaccine literacy assessment tools. Int J Public Health. 2023;68:1605945. doi:10.3389/ijph.2023.1605945.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):6. doi:10.1371/journal.pmed.1000100.
  • Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V. Cochrane handbook for systematic reviews of interventions version 6.2. Cochrane. [ accessed 2021 Feb].
  • Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. 2014. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Siena LM, Isonne C, Sciurti A, De Blasiis MR, Migliara G, Marzuillo C, De Vito C, Villari P, Baccolini V. The Association of health literacy with intention to vaccinate and vaccination status: a systematic review. Vaccines. 2022;10(11):10. doi:10.3390/vaccines10111832.
  • Biasio LR, Giambi C, Fadda G, Lorini C, Bonaccorsi G, D’Ancona F. Validation of an Italian tool to assess vaccine literacy in adulthood vaccination: a pilot study. Ann di Ig Med Prev e di Comunita. 2020;32:205–22.
  • Higgins JPT. Measuring inconsistency in meta-analyses. BMJ Open. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.
  • Biasio LR, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccines Immunother [Internet]. 2021;17(5):1304–12. doi: 10.1080/21645515.2020.1829315.
  • Alshehry AS, Cruz JP, Alquwez N, Alsharari AF, Tork HMM, Almazan JU, Alshammari F, Alabdulaziz H, Alsolami F, Tumala RB, et al. Predictors of nursing students’ intention to receive COVID-19 vaccination: a multi-university study in Saudi Arabia. J Adv Nurs. 2022;78(2):446–57. doi:10.1111/jan.15002.
  • Gendler Y, Ofri L. Investigating the influence of vaccine literacy, vaccine perception and vaccine hesitancy on Israeli parents’ acceptance of the COVID-19 vaccine for their children: a cross-sectional study. Vaccines. 2021;9(12):1391. doi:10.3390/vaccines9121391.
  • Gusar I, Konjevoda S, Babić G, Hnatešen D, Čebohin M, Orlandini R, Dželalija B. Pre-vaccination COVID-19 vaccine literacy in a Croatian adult population: A cross-sectional study. Int J Environ Res Public Health. 2021;18(13):18. doi:10.3390/ijerph18137073.
  • Nath R, Imtiaz A, Nath SD, Hasan E. Role of vaccine hesitancy, eHealth literacy, and vaccine literacy in young adults’ COVID-19 vaccine uptake intention in a lower-middle-income country. Vaccines. 2021;9(12):1405–13. doi:10.3390/vaccines9121405.
  • Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. 2021;9(12):1424. doi:10.3390/vaccines9121424.
  • Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, Hooda D, Khan R, Arora S, Singh A, et al. Assessing COVID-19 booster hesitancy and its correlates: an early evidence from India. Vaccines. 2022;10(7):1–13. doi:10.3390/vaccines10071048.
  • Batra K, Sharma M, Dai CL, Khubchandani J. COVID-19 booster vaccination hesitancy in the United States: a multi-theory-model (MTM)-based national assessment. Vaccines. 2022;10(5):1–15. doi:10.3390/vaccines10050758.
  • Gutierrez JT, Algamdi MM, Alzahrani M, Alwadai A, Alrashidi R, Almrs H, Aljohani R, Alatawi H. Functional, interactive and critical skills literacy among Saudi nationals and the relationship to vaccine acceptance during the COVID-19 pandemic. Biosci Res. 2022;1:370–80.
  • Suzuki T, Ota Y, Sakata N, Fujita N, Kamatsuka M, Nagashima K, Hirayama J, Fujita N, Shiga K, Oyama N, et al. HPV vaccine intention among university students during suspension of active recommendation in Japan. Hum Vaccines Immunother [Internet]. 2022;18(6): doi:10.1080/21645515.2022.2116900.
  • Lee HY, Kwon M, Vang S, Dewolfe J, Kim NK, Lee DK, Yeung M. Disparities in human papillomavirus vaccine literacy and vaccine completion among Asian American pacific islander undergraduates: implications for cancer health equity. J Am Coll Health. 2015;63(5):316–23. doi:10.1080/07448481.2015.1031237.
  • Engelbrecht M, Heunis C, Kigozi G. COVID-19 vaccine hesitancy in South Africa: lessons for future pandemics. Int J Environ Res Public Health. 2022;19(11):6694. doi:10.3390/ijerph19116694.
  • Yilmaz D, Yilmaz DU, Yönt GH. Determining covid-19 vaccine literacy levels of nursing students. Curr Health Sci J. 2022;48:169–75. doi:10.5798/dicletip.1005321.
  • Krishnamurthy K, Sobers N, Kumar A, Ojeh N, Scott A, Cave C, Gupta S, Bradford-King J, Sa B, Adams OP, et al. Covid-19 vaccine intent among health care professionals of Queen Elizabeth Hospital, Barbados. J Multidiscip Healthc. 2021;14:3309–19. doi:10.2147/JMDH.S336952.
  • Kittipimpanon K, Maneesriwongul W, Butsing N, Visudtibhan PJ, Leelacharas S. COVID-19 vaccine literacy, attitudes, and vaccination intention against COVID-19 among Thai older adults. Patient Prefer Adherence. 2022;16:2365–74. doi:10.2147/PPA.S376311.
  • Correa-Rodríguez M, Rueda-Medina B, Callejas-Rubio JL, Ríos-Fernández R, de la Hera-Fernández J, Ortego-Centeno N. COVID-19 vaccine literacy in patients with systemic autoimmune diseases. Curr Psychol [Internet]. 2022;42(16):13769–84. doi: 10.1007/s12144-022-02713-y.
  • Li Y, Guo Y, Wu X, Hu Q, Hu D. The development and preliminary application of the Chinese version of the COVID-19 vaccine literacy scale. Int J Environ Res Public Health. 2022;19(20):13601. doi:10.3390/ijerph192013601.
  • Danis K, Georgakopoulou T, Stavrou T, Laggas D, Panagiotopoulos T. Predictors of childhood vaccination uptake: a cross-sectional study in Greece. Procedia Vaccinol. 2010;2(1):86–91. doi:10.1016/j.provac.2010.03.016.
  • Nasreen S, Gebretekle GB, Lynch M, Kurdina A, Thomas M, Fadel S, Houle SKD, Waite NM, Crowcroft NS, Allin S. Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: a scoping review. Vaccine. 2022;40(32):4380–93. doi: 10.1016/j.vaccine.2022.06.056.
  • Renzi E, Baccolini V, Migliara G, Bellotta C, Ceparano M, Donia P, Marzuillo C, De Vito C, Villari P, Massimi A. Mapping the prevalence of COVID-19 vaccine acceptance at the global and regional level: a systematic review and meta-analysis. Vaccines. 2022;10:1488. doi:10.3390/vaccines10091488.
  • Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15(3):259–67. doi:10.1093/heapro/15.3.259.
  • Cordella B, Signore F, Andreassi S, De DS, Gennaro A, Iuso S, Mannarini T, Kerusauskaite S, Kosic A, Reho M, et al. Social Science & Medicine How socio-institutional contexts and cultural worldviews relate to COVID-19 acceptance rates: a representative study in Italy. Soc Sci Med [Internet]. 2023;320:115671. doi:10.1016/j.socscimed.2023.115671.
  • Bouloukaki I, Christoforaki A, Christodoulakis A, Krasanakis T, Lambraki E, Pateli R, Markakis M, Tsiligianni I. Vaccination coverage and associated factors of COVID-19 uptake in adult primary health care users in Greece. 2023. 1–0.
  • Bornstein MH, Jager J, Putnick DL. Sampling in developmental science: situations, shortcomings, solutions, and standards. NIH Public Access [Internet]. 2013;33(4):357–70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf.
  • World Health Organization. Implementation Guide for Vaccination of Health Workers [Internet]. 2022. https://apps.who.int/iris/bitstream/handle/10665/360603/9789240052154-eng.pdf?sequence=1&isAllowed=y.
  • Mounier-Jack S, Bell S, Chantler T, Edwards A, Yarwood J, Gilbert D, Paterson P. Organisational factors affecting performance in delivering influenza vaccination to staff in NHS acute hospital trusts in England: a qualitative study. Vaccine. 2020;38(15):3079–85. doi:10.1016/j.vaccine.2020.02.077.
  • Guthrie JL, Fisman D, Gardy JL, Olson DR. Self-rated health and reasons for non- vaccination against seasonal influenza in Canadian adults with asthma. PLoS One. 2017;12(2):1–12. doi:10.1371/journal.pone.0172117.